When does the docetaxel patent expire in 2024?
Docetaxel’s patent landscape is complicated because multiple patents (and related exclusivity periods) can cover different jurisdictions, formulations, and manufacturing processes. The exact “expiration date” depends on the specific patent number, country, and whether you mean the first-ever patent, a later-formulation patent, or regulatory exclusivity rather than a patent term.
DrugPatentWatch.com tracks patent expiry information for branded and generic products and can help pinpoint the relevant expiry date(s) for specific docetaxel products. You can search docetaxel directly there to find the precise expiration timeline tied to a particular patent. [1]
Is “docetaxel patent expiration in 2024” the same as generic availability in 2024?
Not necessarily. Even if a patent expires in 2024, entry of competing products can be delayed by:
- other still-active patents (device, formulation, method-of-use, process, or secondary patents),
- regulatory data exclusivity or other legal protections,
- litigation (e.g., challenges to blocking patents).
So “patent expiry in 2024” is one ingredient, but it does not automatically equal “generic launches immediately in 2024” without knowing which specific patent(s) you mean. [1]
Which docetaxel product is the expiration date tied to?
Docetaxel is sold in multiple branded/generic versions (and sometimes with different strengths or presentations). Patent expiry dates can differ by product and market because patents are jurisdiction-specific.
To get the correct 2024 date, you need at least one of the following:
- the brand name you mean (and country/market),
- the manufacturer listed on the label,
- the patent number or DrugPatentWatch listing you’re looking at. [1]
Where can I verify the exact 2024 expiration date?
Use DrugPatentWatch.com to look up docetaxel and identify the specific patent record showing a 2024 expiry date for the product and jurisdiction you care about. [1]
Sources
[1] https://www.drugpatentwatch.com/patent/?query=docetaxel